期刊文献+

颞骨朗格汉斯组织细胞增生症临床分析 被引量:1

Clinical Features of Langerhans Cell Histiocytosis of Temporal Bone
下载PDF
导出
摘要 目的分析颞骨朗格汉斯组织细胞增生症(Langerhans cell histiocytosis,LCH)的临床特点、诊断、治疗和预后。方法回顾性收集解放军总医院耳鼻咽喉头颈外科2009年6月至2014年6月收治并经病理证实的颞骨LCH作为研究对象,按2009年国际组织细胞协会提出的诊断标准、临床分类和疗效评定标准,分析其临床表现、诊断、治疗及预后等临床特点,根据年龄、临床分类分组,比较组间预后差异。结果本组颞骨LCH主要表现为耳漏、耳聋、耳颞部包块、肉芽肿等;16例患者中,幼儿组10例(年龄≤4岁),成人组6例(年龄24岁~68岁),经统计分析组间预后差异无统计学意义。按国际组织细胞协会的分类,多系统组4例,单系统组12例,单系统组预后优于多系统组,差异有统计学意义。结论颞骨LCH临床表现多样,以耳漏和耳聋为常见症状而面神经极少受累,确诊主要靠病理。手术切除是首选治疗方法,颞骨LCH单系统受累患者预后优于多系统受累者。 Objective Temporal bone Langerhans Cell Histiocytosis (LCH) is mainly characterized by otorrhea, mas- toid mass, granuloma in the middle ear and external auditory canal, and hearing loss, while facial paralysis is rare. This study is aimed at analyzing clinical and prognostic features of temporal bone LCH. Methods Clinical data from 16 cases of LCH of the temporal bone treated from July 2009 to July 2014 at the Chinese PLA General Hospital were reviewed, including fol- lowing ups clinical presentation, ,The 2009 International Histocyte Society guidelines for diagnosis, clinical classification and outcome evaluation were adopted in the analysis. Correlation between age and clinical classifications and prognosis was also analyzed. Results Among the 16 patients, 10 were children (≤ 4 years old) and 6 were adults (24 - 68 years old). Multiple system involvement was seen in 4 of the 16 patients, and the rest patients showed only single system involvement. While age was not correlated to treatment outcomes, clinical classification appeared to be correlated to the prognosis. Conclusion The number of organ affected by LCH may be a good prognosis indicator in these patients.
出处 《中华耳科学杂志》 CSCD 北大核心 2015年第1期101-105,共5页 Chinese Journal of Otology
基金 国家自然科学基金面上项目(项目编号:81470683 81170908)
关键词 颞骨 组织细胞增生症 朗格汉斯细胞 诊断 手术 预后 Temproal bone Langerhans histiocytosis Diagnosis Surgery Prognosis
  • 相关文献

参考文献20

  • 1Y.Bayazit,A.Sirikci,M.Bayaram,M.Kanlikama,A.Demir,K.Bakir.Eosinophilic granuloma of the temporal bone.Auris Nasus Larynx.2001,28(1):99—102.
  • 2E.M.Azouz,G.Saigal,M.M.Rodriguez,A.Podda.Langerhans’cell histiocytosis:pathology,imaging and treatment of skeletal involvement.Pediatr.Radiol.2005,35(2):103—115.
  • 3Histiocyte Society.Langerhans cell histiocytosis evaluation and treatment guideline.April,2009.Available from:http://www.heamatologie-amc.nl/odijk/bijlagen.
  • 4Favara BE,Steele A.Langerhans cell histiocytosis of lymph nodes:a morphological assessment of 43 biopsies.Pediatr Pathol Lab Med1997;17(5):769-787.
  • 5Margo CE,Goldman DR,etal.Langethanseellhistioeytosis.Sury OPhthalmol,2008,53(4):332一358.
  • 6Xiaoying Zhang a,1,Dexin Zhu b,1,Hekui Lan.Langerhans cell histiocytosis,a new clinical phenotype of x-linked lymphoproliferative disease?European Journal of Medical Genetics 2011,54(2):165-168.
  • 7Surico G,Muggeo P,Rigillo N,Gadner H.Concurrent Langerhans cell histiocytosis and myelodysplasia in children.Med Pediatr Oncol 2000;35:421-5.
  • 8Scappaticci S,Danesino C,Rossi E,Klersy C,Fiori GM,Clementi R,et al.Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histiocytosis.Brit J Hematol2000;111:258-62.
  • 9Betts DR,Leibundgut KE,Feldges A,Pluss JH,Niggli FK.Cytogenetic abnormalities in Langerhans cell histiocytosis.Br J Cancer1998;77:552-5.
  • 10A.Martini,C.Aimoni,M.Trevisani,P.Marangoni,Langerhans cell histiocytosis:report of a case with temporal localization,Int.J.Pediatr.Otorhinolaryngol.2000,55(1):51-56.

二级参考文献27

  • 1高巧娣,陆凤娟,吴长根,马伴吟,吴玥.小儿郎格罕细胞组织细胞增生症32例临床分析[J].临床儿科杂志,2005,23(2):94-97. 被引量:8
  • 2王赛娟,王旭青,刘勃,陈伟,彭惠兰.朗格罕细胞组织细胞增生症31例临床资料分析[J].中国小儿血液与肿瘤杂志,2006,11(2):82-83. 被引量:4
  • 3农辉图,黄光武,农东晓,陈若泽.耳颞部组织细胞增生症X(附21例报告)[J].中华耳鼻咽喉科杂志,1996,31(6):351-354. 被引量:6
  • 4Irving RM, Broadbent V, Jones NS. Langerhans' cell histiocytosis in childhood: management of head and neck manifestations. Laryngoscope, 1994, 104: 64-70.
  • 5Hermans R, De Foer B, Smet MH, et al. Eosinophilic granuloma of the head and neck : CT and MRI features in three cases. Pediatr Radiol, 1994, 24: 33-36.
  • 6Azouz EM, Saigal G, Rodriguez MM, et al. Langerhans' cell histiocytosis : pathology, imaging and treatment of skeletal involvement. Pediatr Radiol, 2005, 35: 103-115.
  • 7Chu T, D' Anglo GJ, Favara B. Histiocytosis syndromes in Children. Writing Group of the Histiocyte Society. Lancet, 1987, 1 : 208-209.
  • 8Bernstrand C, Carstensen H, Jakobsen B, et al. Immunogenetic heterogeneity in single system and multisystem Langerhans cell histiocytosis. Pediatr Res, 2003, 54 : 30-36.
  • 9Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single system disease in Langerhans cell histiocytosis data from the DAL-HX83- and 90-study. Med Pediatr Oncol, 2001, 37:108-114.
  • 10Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 study Group. Med Pediatr Oncol, 1994, 23:72-80.

共引文献9

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部